330
Views
10
CrossRef citations to date
0
Altmetric
Reviews

Clinical implications for a treatment algorithm and differential indication to hormone therapy and chemotherapy options in metastatic castrate-resistant prostate cancer: a personal view

, , , , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Hiten RH Patel. (2014) Foreword. Expert Review of Anticancer Therapy 14:11, pages 1251-1252.
Read now

Articles from other publishers (9)

Giandomenico Roviello, Martina Catalano, Carlotta Ottanelli, Roberta Giorgione, Virginia Rossi, Elisabetta Gambale, Chiara Casadei, Ugo De Giorgi & Lorenzo Antonuzzo. (2022) Castration-resistant prostate cancer with bone metastases: toward the best therapeutic choice. Medical Oncology 39:10.
Crossref
Gianluca Ingrosso, Beatrice Detti, Daniele Scartoni, Andrea Lancia, Irene Giacomelli, Muhammed Baki, Giulio Carta, Lorenzo Livi & Riccardo Santoni. (2018) Current therapeutic options in metastatic castration-resistant prostate cancer. Seminars in Oncology 45:5-6, pages 303-315.
Crossref
Alessandra Modena, Roberto Iacovelli, Aldo Scarpa, Matteo Brunelli, Chiara Ciccarese, Emanuela Fantinel, Davide Bimbatti, Francesco Massari, Guido Martignoni & Giampaolo Tortora. (2016) Investigating BRCA Mutations: A Breakthrough in Precision Medicine of Castration-Resistant Prostate Cancer. Targeted Oncology 11:5, pages 569-577.
Crossref
Alessandra Modena, Francesco Massari, Chiara Ciccarese, Matteo Brunelli, Matteo Santoni, Rodolfo Montironi, Guido Martignoni & Giampaolo Tortora. (2016) Targeting Met and VEGFR Axis in Metastatic Castration-Resistant Prostate Cancer: ‘Game Over’?. Targeted Oncology 11:4, pages 431-446.
Crossref
Francesco Massari, Alessandra Modena, Chiara Ciccarese, Sara Pilotto, Francesca Maines, Sergio Bracarda, Isabella Sperduti, Diana Giannarelli, Paolo Carlini, Daniele Santini, Giampaolo Tortora, Camillo Porta & Emilio Bria. (2016) Addressing the expected survival benefit for clinical trial design in metastatic castration-resistant prostate cancer: Sensitivity analysis of randomized trials.. Critical Reviews in Oncology/Hematology 98, pages 254-263.
Crossref
Diana Romero, Zainab Al-Shareef, Irantzu Gorroño-Etxebarria, Stephanie Atkins, Frances Turrell, Jyoti Chhetri, Nora Bengoa-Vergniory, Christoph Zenzmaier, Peter Berger, Jonathan Waxman & Robert Kypta. (2016) Dickkopf-3 regulates prostate epithelial cell acinar morphogenesis and prostate cancer cell invasion by limiting TGF-β-dependent activation of matrix metalloproteases. Carcinogenesis 37:1, pages 18-29.
Crossref
Sergio Bracarda, Claudia Caserta, Luca Galli, Paolo Carlini, Ilaria Pastina, Michele Sisani, Simona Scali, Alketa Hamzaj, Lisa Derosa, Alessandra Felici, Marta Rossi, Amelia Altavilla, Aldo Chioni & Verena De Angelis. (2015) Docetaxel rechallenge in metastatic castration-resistant prostate cancer: any place in the modern treatment scenario? An intention to treat evaluation. Future Oncology 11:22, pages 3083-3090.
Crossref
JR Garcia Garzon, Pere Bassa, Marina Soler, Merce Moragas, Elena Llinares & Eduard Riera. (2015) Therapeutic Algorithm Guided by Sequential 11C-Choline PET/CT in a Patient With Metastatic Castration-Resistant Prostate Cancer. Clinical Nuclear Medicine 40:7, pages 600-601.
Crossref
Sergio Bracarda, Amelia Altavilla, Alketa Hamzaj, Michele Sisani, Francesca Marrocolo, Sabrina Del Buono & Riccardo Danielli. (2015) Immunologic Checkpoints Blockade in Renal Cell, Prostate, and Urothelial Malignancies. Seminars in Oncology 42:3, pages 495-505.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.